Therapeuticsmd Inc (TXMD)

12:09 PM

Is TherapeuticsMD Inc. a good long term investmentExceptional growth trajectory - Autocar Professional

12:09 PM

Jul 23, 2025

What analysts say about TherapeuticsMD Inc. stockMarket-crushing stock picks - Autocar Professional

Jul 23, 2025

Jul 23, 2025

TherapeuticsMD Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What drives TherapeuticsMD Inc. stock priceFree Consultation - Autocar Professional

Jul 23, 2025

Jul 16, 2025

How TherapeuticsMD Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser

Jul 16, 2025

Jul 15, 2025

TherapeuticsMD (NASDAQ:TXMD) Shares Down 0.8% – What’s Next? - Defense World

Jul 15, 2025

Jul 15, 2025

What makes TherapeuticsMD Inc. stock price move sharplyIntraday Trade Ideas - Newser

Jul 15, 2025

Jul 15, 2025

Why TherapeuticsMD Inc. stock attracts strong analyst attentionMinimized Risk Maximum Return - Newser

Jul 15, 2025

Jun 01, 2025

Mayne Pharma Group Unit Seeks Over $11.5 Million in Damages in US Court Complaint Against TherapeuticsMD - marketscreener.com

Jun 01, 2025

Jun 01, 2025

Mayne Pharma Files Legal Complaint Against TherapeuticsMD - TipRanks

Jun 01, 2025

May 21, 2025

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World

May 21, 2025

May 15, 2025

TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.com - Defense World

May 15, 2025

May 15, 2025

TherapeuticsMD Reports Improved Q1 2025 Results - TipRanks

May 15, 2025

May 14, 2025

TherapeuticsMD Announces First Quarter 2025 Financial Results | - GuruFocus

May 14, 2025

May 14, 2025

TherapeuticsMD: Q1 Earnings Snapshot - CT Insider

May 14, 2025

May 14, 2025

TherapeuticsMD Announces First Quarter 2025 Financial Results - BioSpace

May 14, 2025

May 13, 2025

TherapeuticsMD Inc Reports Q1 2025 Results: EPS at -$0.06, Revenue Reaches $393K - GuruFocus

May 13, 2025

May 13, 2025

TherapeuticsMD Reports Q1 2025 Financial Results - TipRanks

May 13, 2025

May 13, 2025

TherapeuticsMD Q1 Operating Expenses USD 1.264 Million - marketscreener.com

May 13, 2025

May 12, 2025

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com - Defense World

May 12, 2025

May 04, 2025

Today's Dead Cat Bounce Stock: TherapeuticsMD (TXMD) - TheStreet

May 04, 2025

Apr 28, 2025

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 28, 2025